Navigation Links
Mesa Laboratories, Inc. Added to the Russell Microcap Index
Date:7/7/2008

LAKEWOOD, Colo., July 7 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) announced today that it was added to the Russell Microcap(R) Index when Russell Investments reconstituted its comprehensive family of U.S. indexes on June 27, 2008.

Membership in the Russell Microcap, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies.

"We are pleased with our inclusion in this index, which reflects our continued positive momentum of sales and earnings," said John J. Sullivan, President and COO. "Russell is an industry leader for stock indexes, and we expect our inclusion will generate greater interest in our stock among institutional investors."

Annual reconstitution of Russell indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000(R) Index and Russell Microcap. These investment tools originated from Russell's multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.

About Russell:

Russell Investments aims to improve financial security for people by providing strategic advice, world-class implementation, state-of-the-art performance benchmarks, and a range of institutional-quality investment products. With more than $213 billion in asse
'/>"/>

SOURCE Mesa Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
4. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
5. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
7. Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
10. Bond Laboratories, Inc. Announces 2-for-1 Forward Split
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... disturbances, study finds , , WEDNESDAY...drug ecstasy appears to increase the risk of sleep... ecstasy need to know that this drug damages the b...s such as sleep apnea," study author Dr. Una McCan...imore, said in a news release. , McCann and col...
(Date:12/2/2009)...me, NIH director says, , , WEDNESDAY, D...s have been added to the pool that scientists can ...ch lines will soon be made available, U.S. health ...first additional embryonic stem cell lines approve...tes of Health (NIH) since President Barack Obama l...
(Date:12/2/2009)...Newswire/ -- In the wake of the first evidence tha...stics chemical linked to birth defects and breast ...nfants and mothers. ,, The House and Senate are...food and beverage containers. The bills, by Sen. D...ey of Massachusetts, would protect consumers from ...
(Date:12/2/2009)...part of its continued commitment to hemophilia car...as pledged more than 40 million international unit...tion of Hemophilia (WFH). This is the largest dona...am, and will make a significant impact to advance ...y support building sustainable national care progr...
(Date:12/2/2009)...nt ends nine months of obstruction by SEIU officia...re/ -- More than 2,300 healthcare professionals at...thern California will soon vote on leaving the SEI... (NUHW). ,, A majority of the workers filed pet...the election by filing frivolous charges which wer...
Breaking Medicine News(10 mins):Health News:Ecstasy Users at Higher Risk of Sleep Apnea 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA 2Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2
...lementing NextGen(R) Suite of Integrated Electroni... Applications, PLANO, Texas, Feb. 22 Today Perot...lthcare announced their newly,implemented revenue ... increased Oakwood,s revenue cycle performance,and...
...., Feb. 22 Sutter Health is creating a,network of...and specialist,physicians committed to providing p...y high-quality health care services. The Sutter Me... Cruz,to the Mother Lode foothills., By joining t...
...st Biologic Treatment Approved in Nine Years for C...ating Autoimmune Disease, ABBOTT PARK, Ill., Feb....eceived U.S. Food and Drug Administration (FDA),ap... arthritis (JIA) in patients four years of age and...
...Extensive IT, Sales and Large-Project Management ...rtner Channel, BLOOMFIELD HILLS, Mich., Feb. 22 ...records (EHR) software and practice,management sol...e management team as chief channel officer., In h...
... 22 Ceremed, Inc., a medical device,corporation, ...Ruggiero as,its new Vice President for Sales and B...d and its affiliate corporation, Bioplate, Inc. at...responsibilities on February 25th., Mr. Ruggiero ...
... Feb. 22 STAAR Surgical,Company (Nasdaq: STAA ) ...ults for the fourth quarter ended December 28, 200...e. The Company will host a conference call and,web...er for the conference call is 800-257-7063 for dom...
Other Medicine News:Health News:Perot Systems and Oakwood Healthcare Deliver Advanced Technology & Revenue Cycle Solutions to Physicians 2Health News:Perot Systems and Oakwood Healthcare Deliver Advanced Technology & Revenue Cycle Solutions to Physicians 3Health News:Sutter Health Launches Northern California Physician Network 2Health News:Sutter Health Launches Northern California Physician Network 3Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 2Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 3Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 4Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 5Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 6Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 7Health News:Nationally Recognized Information Technology Veteran and Entrepreneur John Bamberger Joins gloStream, Inc. as Chief Channel Officer 2Health News:Ceremed Appoints Vice President for Sales and Business Development 2Health News:STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call 2
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 ... a late-breaking presentation on Tasigna® (ni...oid leukemia, demonstrate the strength of the comp...f patients. ,, The new data, at the 51st Ameri... Exposition, highlight the company,s current thera...
(Date:12/1/2009)...TEMECULA, Calif., Dec. 1 ...oard: PSTX) announced today that it has appointed ...nancial Officer, Treasurer and Corporate Secretary...ince 2008. Prior to joining Patient Safety Techno... Chief Financial Officer, Treasurer and Corporate ...
(Date:12/1/2009)...EDONDO BEACH, Calif., Dec. 1 Repro...ir Elective Single Embryo Transfer (eSET) Encourag... patients with good embryo quality and a good prog...of twins by transferring a single embryo. ,, Th...y today is reducing the number of multiple pregnan...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2Celebrity Fitness Trainer Valerie Waters Offers On the Go Families Back to Basics Tips 56067 1Celebrity Fitness Trainer Valerie Waters Offers On the Go Families Back to Basics Tips 56067 2Celebrity Fitness Trainer Valerie Waters Offers On the Go Families Back to Basics Tips 56067 3Celebrity Fitness Trainer Valerie Waters Offers On the Go Families Back to Basics Tips 56067 4Minnesota Health Improvement Leaders Honored 56064 1Minnesota Health Improvement Leaders Honored 56064 2Minnesota Health Improvement Leaders Honored 56064 3Tanning Beds as Harmful as Tanning in the Sun Reports Harvard Women 26apos 3Bs Health Watch 56061 1Tanning Beds as Harmful as Tanning in the Sun Reports Harvard Women 26apos 3Bs Health Watch 56061 2
...N, April 3, 2007-Newly published results in the,In...he large-scale,observational ‘PREDICTIVE&tr...the majority of people effectively treats diabetes...trade; study is examining patient outcomes when,Le...dash; is used,in the everyday clinical setting. In...
...Assays Show rBChE Suppresses Amyloid Plaque,Format... Inc., a leading,biodefense company specializing i... countermeasures against chemical and,biological t...ecombinant butyrylcholinesterase (rBChE) research ...tional Conference on,Alzheimer,s and Parkinson,s D...
Other Medicine Technology:New Data Confirm That Use of Levemir Can Limit Weight Gain 2New Data Confirm That Use of Levemir Can Limit Weight Gain 3New Data Confirm That Use of Levemir Can Limit Weight Gain 4New Data Confirm That Use of Levemir Can Limit Weight Gain 5New Data Confirm That Use of Levemir Can Limit Weight Gain 6Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6
Storz Suturing Forceps
VanRens Sleeve Spreading Forceps
Madlab Biopsy Forceps
Olk Membrane Peeler
Medicine Products: